Teguh Haryo

Dr. Teguh Haryo

orcid

Research Focus & Metrics

Representative Publications

View All Publications
1 January 2009 in Brain and Development
Verified
Journal Article
Closed access
MWMohd Shamshudin Watihayati
Mohd Shamshudin Watihayati
HFHayati Fatemeh
Hayati Fatemeh
MMMarzuki Marini
Marzuki Marini
AAAmin Baig Atif
Amin Baig Atif
WMWan Mohd Zahiruddin Wan Mohammad
Wan Mohd Zahiruddin Wan Mohammad
BZBin Alwi Zilfalil
Bin Alwi Zilfalil

13 July 2016 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
THTeguh Haryo
Teguh Haryo
NINur Farrah Dila Ismail
Nur Farrah Dila Ismail
ZZZamh Zabidi-Hussin
Zamh Zabidi-Hussin

6 April 2007 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
TKTomohiro Kotani
Tomohiro Kotani
RSRetno Sutomo
Retno Sutomo
THTeguh Haryo
Teguh Haryo
ASAhmad Hamim Sadewa
Ahmad Hamim Sadewa
GUGunadi
Gunadi
HNHisahide Nishio
Hisahide Nishio

1 January 2013 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
JMJafar Mohseni
Jafar Mohseni
ZZZ.A.M.H. Zabidi-Hussin
Z.A.M.H. Zabidi-Hussin
THTeguh Haryo
Teguh Haryo
Histone acetylation plays an important role in regulation of transcription in eukaryotic cells by promoting a more relaxed chromatin structure necessary for transcriptional activation. Histone deacetylases (HDACs) remove acetyl groups and suppress gene expression. HDAC inhibitors (HDACIs) are a group of small molecules that promote gene transcription by chromatin remodeling and have been extensively studied as potential drugs for treating of spinal muscular atrophy. Various drugs in this class have been studied with regard to their efficacy in increasing the expression of survival of motor neuron (SMN) protein. In this review, we discuss the current literature on this topic and summarize the findings of the main studies in this field.

29 May 2008 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
VTVan Khanh Tran
Van Khanh Tran
THTeguh Haryo
Teguh Haryo
DHDang Diem Hong
Dang Diem Hong
NHNguyen Thi Hoan
Nguyen Thi Hoan
VDVu Chi Dung
Vu Chi Dung
HNHisahide Nishio
Hisahide Nishio

19 March 2011 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
AAAlyaa Al-Khateeb
Alyaa Al-Khateeb
MZMohd K Zahri
Mohd K Zahri
MMMohd S Mohamed
Mohd S Mohamed
THTeguh Haryo
Teguh Haryo
SISuhairi Ibrahim
Suhairi Ibrahim
BZBin Alwi Zilfalil
Bin Alwi Zilfalil
Background: Familial hypercholesterolemia is a genetic disorder mainly caused by defects in the low-density lipoprotein receptor gene. Few and limited analyses of familial hypercholesterolemia have been performed in Malaysia, and the underlying mutations therefore remain largely unknown. We studied a group of 154 unrelated FH patients from a northern area of Malaysia (Kelantan). The promoter region and exons 2-15 of the LDLR gene were screened by denaturing high-performance liquid chromatography to detect short deletions and nucleotide substitutions, and by multiplex ligation-dependent probe amplification to detect large rearrangements. Results: A total of 29 gene sequence variants were reported in 117(76.0%) of the studied subjects. Eight different mutations (1 large rearrangement, 1 short deletion, 5 missense mutations, and 1 splice site mutation), and 21 variants. Eight gene sequence variants were reported for the first time and they were noticed in familial hypercholesterolemic patients, but not in controls (p.Asp100Asp, p.Asp139His, p.Arg471Gly, c.1705+117 T>G, c.1186+41T>A, 1705+112C>G, Dup exon 12 and p.Trp666ProfsX45). The incidence of the p.Arg471Gly variant was 11%. Patients with pathogenic mutations were younger, had significantly higher incidences of cardiovascular disease, xanthomas, and family history of hyperlipidemia, together with significantly higher total cholesterol and low density lipoprotein levels than patients with non-pathogenic variants. Conclusions: Twenty-nine gene sequence variants occurred among FH patients; those with predicted pathogenicity were associated with higher incidences of cardiovascular diseases, tendon xanthomas, and higher total and low density lipoprotein levels compared to the rest. These results provide preliminary information on the mutation spectrum of this gene among patients with FH in Malaysia.